OTCPK:MFST

Stock Analysis Report

Executive Summary

Medifirst Solutions, Inc., a development stage company, focuses on developing products within the healthcare market for consumer and professional applications.

Snowflake

Fundamentals

Weak fundamentals or lack of information.

Share Price & News

How has Medifirst Solutions's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-10.8%

MFST

1.7%

US Medical Equipment

2.3%

US Market


1 Year Return

-89.3%

MFST

10.1%

US Medical Equipment

5.6%

US Market

Return vs Industry: MFST underperformed the US Medical Equipment industry which returned 10.1% over the past year.

Return vs Market: MFST underperformed the US Market which returned 5.6% over the past year.


Shareholder returns

MFSTIndustryMarket
7 Day-10.8%1.7%2.3%
30 Day-61.1%-1.7%-1.0%
90 Day-81.3%-1.7%-0.7%
1 Year-89.3%-89.3%11.0%10.1%7.9%5.6%
3 Year-99.9%-99.9%70.4%65.2%45.6%36.3%
5 Year-100.0%-100.0%128.5%103.2%65.8%47.6%

Price Volatility Vs. Market

How volatile is Medifirst Solutions's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Medifirst Solutions undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether Medifirst Solutions is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Medifirst Solutions has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of MFST’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Medifirst Solutions regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Medifirst Solutions forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

23.5%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Medifirst Solutions has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of MFST’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Medifirst Solutions's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has Medifirst Solutions performed over the past 5 years?

-31.5%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: MFST is unprofitable, and losses have increased over the past 5 years at a rate of -31.5% per year.

Accelerating Growth: Unable to compare MFST's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MFST is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (28.2%).


Return on Equity

High ROE: MFST's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets

ROA vs Industry: MFST is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: MFST is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is Medifirst Solutions's financial position?


Financial Position Analysis

Short Term Liabilities: MFST has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: MFST has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: MFST has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: MFST's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet

Inventory Level: MFST has a low level of unsold assets or inventory.

Debt Coverage by Assets: MFST has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: MFST has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: MFST has less than a year of cash runway if free cash flow continues to reduce at historical rates of -18.7% each year


Next Steps

Dividend

What is Medifirst Solutions's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.5%markettop25%3.8%industryaverage1.2%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate MFST's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate MFST's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if MFST's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MFST's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of MFST's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of Medifirst Solutions's salary, the management and board of directors tenure and is there insider trading?

2.2yrs

Average management tenure


CEO

Bruce Schoengood (61yo)

8.6yrs

Tenure

US$150,000

Compensation

Mr. Bruce J. Schoengood has been the Chief Executive Officer and Chief Financial Officer of Medifirst Solutions, Inc since March 16, 2011 and serves as its President. Mr. Schoengood serves as the Chief Exe ...


CEO Compensation Analysis

Compensation vs. Market: Bruce's total compensation ($USD150.00K) is about average for companies of similar size in the US market ($USD493.00K).

Compensation vs Earnings: Bruce's compensation has increased whilst the company is unprofitable.


Management Age and Tenure

2.2yrs

Average Tenure

Experienced Management: MFST's management team is considered experienced (2.2 years average tenure).


Board Age and Tenure

6.0yrs

Average Tenure

61yo

Average Age

Experienced Board: MFST's board of directors are considered experienced (6 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

BuyUS$6,76302 May 19
James Besser
EntityIndividual
Shares96,612
Max PriceUS$0.07

Ownership Breakdown


Management Team

  • Bruce Schoengood (61yo)

    President

    • Tenure: 8.6yrs
    • Compensation: US$150.00k
  • Ron Rubin

    Chief Medical Officer & First Member of Advisory Board

    • Tenure: 6.6yrs
  • Colin Wu

    Executive Advisor to CEO & Member of Advisory Board

    • Tenure: 2.2yrs
  • Walter Molokie

    Chief Executive Officer of Concierge Concepts Rx

    • Tenure: 1.4yrs

Board Members

  • Richard Berman (76yo)

    Member of Advisory Board

    • Tenure: 3.2yrs
  • Bruce Schoengood (61yo)

    President

    • Tenure: 8.6yrs
    • Compensation: US$150.00k
  • Bill White (58yo)

    Member of Advisory Board

    • Tenure: 2.9yrs
  • Ron Rubin

    Chief Medical Officer & First Member of Advisory Board

    • Tenure: 6.6yrs
  • Fred Valdez

    Member of Advisory Board

    • Tenure: 6.6yrs
  • Kenneth Pearlberg

    Member of Advisory Board

    • Tenure: 6.5yrs
  • Sree Reddy

    Member of Advisory Board

    • Tenure: 5.5yrs
  • Colin Wu

    Executive Advisor to CEO & Member of Advisory Board

    • Tenure: 2.2yrs

Company Information

Medifirst Solutions, Inc's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Medifirst Solutions, Inc
  • Ticker: MFST
  • Exchange: OTCPK
  • Founded: 2010
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$268.721k
  • Shares outstanding: 46.33m
  • Website: https://www.medifirstsolutions.com

Number of Employees


Location

  • Medifirst Solutions, Inc
  • 4400 Route 9 South
  • Suite 1000
  • Freehold
  • New Jersey
  • 7728
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MFSTOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDJul 2012

Biography

Medifirst Solutions, Inc., a development stage company, focuses on developing products within the healthcare market for consumer and professional applications. It develops a hand-held mobile laser system,  ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/18 00:28
End of Day Share Price2019/10/16 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.